Preclinical evaluation of rBCG-h12: an engineered Bacillus Calmette-Guérin with an enhanced activity against bladder and pancreatic cancers.

Cancer Immunol Immunother · 2026 · PMC13442775 · PMID 42223672

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

6 h) and showed a clear trend toward inverse association with tumor growth (pancreatic weights) (Fig. 6 i).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.